Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Najla E. Al Ali"'
Autor:
Quinto J Gesiotto, David M Swoboda, Najla E. Al Ali, Eric Padron, Andrew T. Kuykendall, Jinming Song, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Rami Komrokji, David A. Sallman
Publikováno v:
Blood. 136:4-5
Background: Checkpoint inhibitors, for example anti-PD-1 antibodies (e.g. nivolumab and pembrolizumab) and anti-CTLA-4 antibodies (e.g. ipilimumab), have changed the paradigm of many solid tumors although in myeloid malignancies responses have been l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a7f661b46d28b3468fb5bad04c415a
https://doi.org/10.1182/blood-2020-140861
https://doi.org/10.1182/blood-2020-140861
